Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Public health policy

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    3 result(s) found for: Public health policy. Displaying page 1 of 1.
    EudraCT Number: 2015-003250-41 Sponsor Protocol Number: 1 Start Date*: 2015-09-15
    Sponsor Name:Public Health England
    Full Title: Protection induced by Live Attenuated Influenza Vaccine (LAIV or Fluenz Tetra) - applied epidemiological study
    Medical condition: There is no medical condition associated with this trial. The trial involves vaccination of healthy children with a licensed product according to the SmPC. The vaccination is Fluenz Tetra, a live...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10016794 Flu vaccination LLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2016-002381-31 Sponsor Protocol Number: Quadrimeningofollowu Start Date*: 2016-07-22
    Sponsor Name:Public Health England
    Full Title: An observational follow up study of a phase II/III, open label, randomised study of the safety, reactogenicity and immunogenicity of a single dose of meningococcal ACWY conjugate vaccine (Menveo, G...
    Medical condition: No specific medical condition(s) - responses to vaccination against meningococcal disease.
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10027199 Meningitis PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-004495-34 Sponsor Protocol Number: iMAP2 Start Date*: 2014-03-11
    Sponsor Name:Public Health England
    Full Title: A randomised controlled trial comparing two pertussis-containing vaccines in pregnancy and vaccine responses in UK mothers and their infants (immunising Mums Against Pertussis, iMAP2)
    Medical condition: No medical condition or disease, instead responses to immunisations against pertussis (whooping cough) in mothers and against pertussis (whooping cough), tetanus, diphtheria, Hib, meningococcal C a...
    Disease: Version SOC Term Classification Code Term Level
    16.1 10018065 - General disorders and administration site conditions 10059080 Vaccination site reaction PT
    16.1 10042613 - Surgical and medical procedures 10054175 Polio immunisation PT
    16.1 10042613 - Surgical and medical procedures 10054131 Tetanus immunisation PT
    16.1 10042613 - Surgical and medical procedures 10069578 Pneumococcal immunisation PT
    16.1 10042613 - Surgical and medical procedures 10054129 Diphtheria immunisation PT
    16.1 100000004862 10047976 Whooping cough due to bordetella pertussis (B. pertussis) LLT
    16.1 10042613 - Surgical and medical procedures 10069577 Pertussis immunisation PT
    16.1 10042613 - Surgical and medical procedures 10063021 Primary immunisation LLT
    16.1 10042613 - Surgical and medical procedures 10046859 Vaccination LLT
    16.1 10042613 - Surgical and medical procedures 10021430 Immunisation PT
    16.1 10042613 - Surgical and medical procedures 10069533 Haemophilus influenzae type b immunisation PT
    16.1 10018065 - General disorders and administration site conditions 10069620 Vaccination site swelling PT
    16.1 10042613 - Surgical and medical procedures 10039244 Routine vaccination LLT
    16.1 10042613 - Surgical and medical procedures 10034101 Passive immunisation LLT
    16.1 10042613 - Surgical and medical procedures 10039243 Routine immunisation LLT
    16.1 10042613 - Surgical and medical procedures 10039242 Routine childhood immunisation LLT
    Population Age: Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 01 08:25:53 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA